Interesting alternative to insulin got the nod from an advisory panel today...if it gets FDA approval this could be a popular drug:
FDA panel backs MannKind Corp.'s diabetes drug Afrezza - latimes.com
FDA panel backs MannKind Corp.'s diabetes drug Afrezza - latimes.com
